J. Douglas Bremner See book keywords and concepts | Developed in 1995 by a consortium of pharmaceutical-industry representatives, state mental-health facilities, and the University of Texas, tmap recommends first-line use of patented medications for treatment of mental disorders in spite of the fact that there is no evidence that they are better than older medications. A program in Indiana modeled after tmap, called TeenScreen, used passive screening, where schools were allowed to test children for mental disorders if the parents did not return a form to the school specifically asking them not to. | Jacky Law See book keywords and concepts | This, he continued, was poised to consolidate the tmap effort into a comprehensive national policy to treat mental illness with expensive, patented medications of questionable benefit and deadly side effects, and to force private insurers to pick up more of the tab.20
Larry D. Sasich of the watchdog group, Public Citizen, said most studies suggest using the older drugs first makes sense.
There's nothing in the labelling of the newer atypical antipsychotic drugs that suggests they are superior in efficacy to haloperidol [an older 'typical' antipsychotic]. | Kelly Patricia O'Meara See book keywords and concepts | The drug companies involved in financing and/or directly creating and marketing tmap include: Janssen Pharmaceutica, Johnson & Johnson, Eli Lilly, AstraZeneca, Pfizer, Novartis, Janssen-Ortho-McNeil, GlaxoSmithKline,
Abbott, Bristol Myers Squibb, Wyeth-Ayerst, Forest Laboratories and U.S. Pharmacopeia.
6. Janssen was the most aggressive of the companies in developing this model and in directly compromising and influencing public officials. All of the other companies mentioned contributed funding to the effort.
7. | | Allen Jones, an investigator in the Commonwealth of Pennsylvania Office of the Inspector General, Bureau of Special Investigations, is intimately familiar with the pharmaceutical power behind tmap, and alleges in a whistleblower lawsuit that he was wrongfully removed from his investigation for his attempts to expose evidence of major pharmaceutical wrongdoing during his investigation of the Model Program being implemented in Pennsylvania. During his investigation, Jones uncovered the following:
1. | | What is of additional interest is the extraordinary pharmaceutical support provided during the process of formulating the tmap, which will be utilized once the mental illness diagnosis has been made. | | Considering the above, it's as if the benevolent ones sitting on the NFC had lost all sense of logic and reason and still recommended the tmap as the standard, despite the fact that many of the mind-altering drugs intended for use in the algorithm have not been approved for adolescent use. Still hearing "God Bless America" in the background? | | Based on the adult version of the tmap, let's review a scenario that may be representative of what America's children will have to endure if subjected to a similar algorithm. A child is diagnosed with an alleged psychiatric mental illness and the physician is instructed to follow the algorithm chart of treatments. So, in the first stage, a mind-altering antidepressant is prescribed and, in some arbitrary amount of time, if there is no improvement of the alleged psychiatric mental illness, the child is moved to Stage 2. | | It is difficult to know where to begin when addressing the tmap and how the NFC possibly could conclude the algorithm is the best course of action when it comes to treatment for the alleged psychiatric mental illnesses from which the nation's adult population is suffering, let alone its children. A good place to start may be in first acknowledging that there is no scientific method in which physicians can determine the level of any person's depression because there is no objective, confirmable abnormality found in the human brain that is depression.
Do children get depressed? Yes, of course. |
FAIR USE NOTICE: The research quoted here is provided under the protection of Fair Use provisions and published by the 501(c)3 non-profit Consumer Wellness Center for the purposes of public comment and education. Authors / publishers may submit books for consideration of inclusion here.
TERMS OF USE: Read full terms of use. Citations of text from NaturalPedia must include: 1) Full credit to the original author and book title. 2) Secondary credit to the Natural News Naturalpedia as a research resource and a link to www.NaturalNews.com/np/index.html
This unique compilation of research is copyright (c) 2008 by the non-profit Consumer Wellness Center.
ABOUT THE CREATOR OF NATURALPEDIA: Mike Adams, the creator of this NaturalNews Naturalpedia, is the editor of NaturalNews.com, the internet's top natural health news site, creator of the Honest Food Guide (www.HonestFoodGuide.org), a free downloadable consumer food guide based on natural health principles, author of Grocery Warning, The 7 Laws of Nutrition, Natural Health Solutions, and many other books available at www.TruthPublishing.com, creator of the earth-friendly EcoLEDs company (www.EcoLEDs.com) that manufactures energy-efficient LED lighting products, founder of Arial Software (www.ArialSoftware.com), a permission e-mail technology company, creator of the CounterThink Cartoon series (www.NaturalNews.com/index-cartoons.html) and author of over 1,500 articles, interviews, special reports and reference guides available at www.NaturalNews.com. Adams' personal philosophy and health statistics are available at www.HealthRanger.org.
|
 |
Refine your search
with Tmap...
...and Key Health Concepts:...and Drugs ...and Drug ...and Medication ...and Treatment ...and Medications ...and Health ...and Chemical ...and Pharmaceutical industry ...and Illness ...and Side effects
...and Concepts:...and Model ...and Program ...and Science ...and Illnesses ...and Mental health ...and Group ...and Clinical studies ...and Marketing ...and Study ...and Guidelines
...and Adjectives:...and Clinical ...and New ...and Recommended ...and Total ...and Public ...and Major ...and Superior ...and Aggressive ...and National ...and Mass
...and Who:...and Doctors ...and Children ...and Physician ...and Patients ...and Physicians ...and Child ...and For children ...and Adults ...and Patient ...and Americans
...and Objects:...and Companies ...and Questions ...and Review ...and Industry ...and Report ...and People ...and Strategies ...and Market ...and Pill ...and Prescriptions
|
Related Concepts:
Drugs Model Program Doctors Companies Janssen Mental Children Drug Medication Questions Psychiatrists Johnson Antidepressant Clinical Review Treatment Medications Health Science Eli lilly Astrazeneca Chemical Mental illness New Recommended Illnesses America Mental health Physician Patients Pennsylvania Jones Physicians Total Zyprexa Seroquel Serzone Wellbutrin Drug companies Clinical studies Mind-altering drugs Group Marketing Drug trials Lilly Choosing Hard science Depression Public Study New drugs Guidelines Recommendations Pfizer Johnson & johnson Major Eli Creating Menus Structure Superior Novartis U.s. pharmacopeia Prozac Laboratories Public officials Antidepressants Industry Pharmaceutical industry Developing Paxil Glaxosmithkline Zoloft Treatments Bristol myers squibb Child Myers Wyeth-ayerst Aggressive Trials Illness Adderall Depakote Funding Effects Teenscreen Levels National Brain Texas Fda Report Mass Atypical Ssri Investigations Ohio Special Increase
|